Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

Osteoarthritis and Cartilage - Tập 22 - Trang 415-430 - 2014
E. Losina1,2,3,4, S.A. Burbine1, L.G. Suter5, D.J. Hunter6, D.H. Solomon2,3, M.E. Daigle1, E.E. Dervan1, J.M. Jordan7, J.N. Katz1,2,3
1Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA
2Section of Clinical Sciences, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
4Boston University School of Public Health, Boston, MA, USA
5Yale University, New Haven, CT, USA
6University of Sydney and Royal North Shore Hospital, Sydney, Australia
7Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Osteoarthritis and Cartilage

Tập 22

415-430

Thông tin tác giả